A groundbreaking preclinical study found that intranasal nano-encapsulated ivermectin safely shrank glioblastoma tumors by up to 70% in animal models—without signs of toxicity and at doses lower than standard antiparasitic use.
>>Read the study here: Intranasal Delivery of Ivermectin Nanosystems as an Antitumor Agent: Focusing on Glioma Suppression
